Ampio Pharmaceuticals Inc (NYSEMKT: AMPE)
Ampio Pharmaceuticals is having an incredibly strong day in the market today. When the opening bell rang, the stock quickly found itself well into the green. Through the the trading session, the stock has continued climbing higher and higher. Below, we’ll talk about what we’re seeing from the stock, why, and what we’ll be watching for with regard to AMPE ahead.
What We’re Seeing From AMPE
As mentioned above, Ampio Pharmaceuticals is having an incredibly strong start to the trading session today. When the opening bell rang, the stock started spiking upward. Throughout the day, it hasn’t stopped the upward trajectory. At the moment (11:18), AMPE is trading at $1.02 per share after a gain of $0.22 per share (26.88%) thus far today.
Why The Stock Is Climbing
As usual, as soon as the CNA Finance team noticed that AMPE was climbing so high, we started to do some digging to see exactly what was causing the movement. In this particular case, it took a bit more digging than usual, but we believe we’ve found the cause.
Scattered throughout the social space, we’re seeing quite a bit of chatter about Ampio Pharmaceuticals. Particularly, there’s a bit of chatter about expectations of news with regard to Ampion. At this point, the treatment isn’t far from a BLA being filed for osteoarthritis of the Knee (OAK). However, it’s important to keep in mind that we have heard no news from the company, nor have they confirmed that news with regard to the treatment will be coming soon.
What We’ll Be Watching For Ahead
Moving forward, the CNA Finance team will be be keeping a close eye on AMPE. In particular, we’ll be watching news with regard to the company’s flagship candidate, Ampion. Any news surrounding the potential treatment could cause big movement on the stock. Nonetheless, we’ll keep a close eye on the news and be sure to update you as it breaks!
Never Miss The News Again
Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!
[Image Courtesy of Flickr]